Articles

June 7, 2020 Alnylam Leaders at BIO International Convention 2020/"Digital BIO" Even though the BIO International Convention has gone virtual for 2020 as a result of COVID-19, Alnylam leaders will continue to contribute to the... Read More ›
June 2, 2020 Announcing the 2019-2020 Advocacy for Impact Grant Recipients The Alnylam 2019-2020 Advocacy for Impact grant recipients come from five countries across three continents, and will receive grants totaling USD $270,000.00... Read More ›
June 1, 2020 We Stand Against All Forms of Racism and Discrimination On June 1, 2020, we issued the following public statement in response to events unfolding in the United States as a result of the killing of George Floyd... Read More ›
May 12, 2020 Alnylam Named a Great Place to Work in the UK and Switzerland for Second Year in a Row Alnylam has been recognized for the second year in a row as a Best Workplace 2020 in the UK and in Switzerland. Read More ›
May 6, 2020 Navigating the Winding Road to Drug Approvals Learn about the winding road and key members involved in getting a new drug approved. Read More ›
March 30, 2020 Alnylam's Response to COVID-19 Learn more about Alnylam's response to the COVID-19 pandemic. Read More ›
March 6, 2020 IWD 2020: Alnylam Women Reflect on Personal Experiences & Inspiration We asked Alnylam women from across the globe to share to share a personal experience or inspiration that has shaped how they view gender and science at work. Read More ›
February 25, 2020 Advocacy for Impact Grants: Updates from the Field Learn about how patient organizations who received 2018-2019 Alnylam Advocacy for Impact Grants have been putting those funds to work. Read More ›
February 19, 2020 Making Strides in Gender Parity Alnylam ranked #3 in gender parity and #1 in fair representation for Women of Color (WOC) in Executive and Board Leadership among the top 25 employers in MA. Read More ›
January 9, 2020 Expressing the Puzzling Challenges of hATTR Amyloidosis Through Art We recently spoke with Peggy and her life partner Dan, who is living with hATTR amyloidosis, about their submission, At the Coffee Shop.  Read More ›
Subscribe to Articles

Get In Touch

Have any questions or comments about the content you see on this page?

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site